Levetiracetam appears to reduce phasic spasticity in patients with multiple sclerosis

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1423, 2004-01, pp. : 18-18

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost Effectiveness of Oromucosal Cannabis-Based Medicine (Sativex®) for Spasticity in Multiple Sclerosis

By Lu Lanting Pearce Hilary

PharmacoEconomics, Vol. 30, Iss. 12, 2012-12 ,pp. : 1157-1171

Adis International

Access to resources Recommend Favorite

AT-1001 appears to reduce intestinal barrier dysfunction in patients with coeliac disease

Inpharma, Vol. 1, Iss. 1610, 2007-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Rosuvastatin treatment appears to reduce disease activity in patients with ankylosing spondylitis

Inpharma, Vol. 1, Iss. 1541, 2006-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Gabapentin appears to improve symptoms and reduce postural instability in patients with orthostatic tremor

Inpharma, Vol. 1, Iss. 1552, 2006-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Dronabinol appears to reduce tics in patients with Gilles de la Tourette's syndrome

Inpharma, Vol. 1, Iss. 1391, 2003-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite